Insights

Manufacturers

Podcast: Collaborative perseverance to bring change to medicine access

Pharmacies

3 ways your distributor can help you prepare for DSCSA compliance

Manufacturers

Recap AMCP 2023: Our thought leadership in action

Manufacturers

Optimize your pre-approval information exchange strategy

Evolving advanced therapy medicinal product regulations require new logistics complexity

Regulators tightening cell and gene therapies logistics controls to assure patient safety and security

Manufacturers

HTA Quarterly | Spring 2023

Time to adapt Europe’s evolving cell and gene therapy regulatory framework before it prevents patient access due to logistics hurdles

Pharmacies

DSCSA: Are you ready for November 2023?

Manufacturers

Education: The centerpiece of biosimilar adoption

With landmark approval, spotlight on cryogenic logistics intensifies

Manufacturers

HTA Quarterly | Summer 2023

Manufacturers

HTA Quarterly | Winter 2022

Manufacturers

Podcast: Conversations around interchangeability and biosimilar entries in new therapeutic categories

Manufacturers

Closing the gaps in pre-approval information exchange to accelerate product success and patient access

Manufacturers

Market access abroad: Three reasons why early planning is critical for HTA countries

Manufacturers

Podcast: Milestones for biosimilars in 2022 and looking ahead to 2023

Patients lose if we don't continue to expand pharmacy-based clinical care in the U.S.

Webinar: Debunking common PIE misperceptions to enhance your PIE strategy and tactics

Physician Practices

Q&A: Legislative updates and healthcare advocacy report

Manufacturers

Health policy and the political landscape

Affordability is about more than drug prices

Manufacturers

The Value of Real-World Evidence in Canadian Drug Commercialization: Part 2

Manufacturers

Strategies for addressing copay accumulators: What manufacturers need to know

Let's Ditch 2020 and Plan for 2021: Election What-Ifs

Health Systems

Biosimilars: Patents, policy, and reimbursement

Physician Practices

COVID-19 Resources

Manufacturers

Commercializing in Canada: Quality Assurance and GMP Services

Manufacturers

Commercializing in Canada: Regulatory Publishing and Submissions

Physician Practices

How COVID-19 is Altering Telehealth

Physician Practices

Cybersecurity and Working Virtually During the Pandemic

Health Systems

Partnering With Your Distributor for USP 800 Compliance

Manufacturers

Mind the (Evidence) Gap

Manufacturers

InnomarLive 2019: Commercializing in Canada